Lori Ann Kehler

New directorship holder are: (front row, from left) Jonathan Soslow, MD, MSCI; Jill Simmons, MD; Lori Jordan, MD, PhD; Janice Law, MD; Angela Jefferson, PhD; Carrie Menser, MD; Muktar Aliyu, MBBS, DrPH, MPH; Tracy Frech, MD, MSCI; Peter Embí, MD, MS, (back row, from left) Meredith Pugh, MD, MSCI; Stephen Patrick, MD, MPH, MS; Harvey Murff, MD, MPH; John Graves, PhD; Paul Sternberg Jr., MD; Joshua Robinson, OD; Fabien Maldonado, MD, MSc; Jonathan Brown, MD; Lori Ann Kehler, OD; and Julie Lounds Taylor, PhD. (photo by Donn Jones)

Directorships honor leaders, philanthropic partners

Nineteen leaders have been named as holders of directorships at Vanderbilt University Medical Center.

Smiling young African girl with long curly hair wearing glasses while standing alone against a gray background

VUMC participates in national study to test eye drops for nearsightedness in children

A multi-institutional study found that low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

Lori Ann Kehler, OD, gives a low vision exam to patient Mary Elizabeth Parker at the Vanderbilt Eye Institute.

Low vision initiative for children lands new funding

Vanderbilt’s Project PAVE has received funding from the Tennessee Department of Intellectual and Developmental Disabilities to continue the program that has provided low-vision evaluations for more than 2,150 school-age children in Tennessee since 1993.

Smiling young African girl with long curly hair wearing glasses while standing alone against a gray background

Study explores new treatment for childhood myopia

The rates of myopia, or nearsightedness, in pediatric patients have steadily increased with little to no change in treatment, which, for decades, has had ophthalmologists and optometrists turning to corrective lenses for improved vision.

Project PAVE’s impact on children’s vision easy to see

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.